The full results of these experiments will be presented by Emini at the Keystone Conference on HIV Vaccine Development, an annual gathering of HIV researchers, on March 31.
Shiver and a colleague, Merck Senior Vice President of vaccine research Emilio Emini , approached Aventis several years ago about testing Aventis' vaccines in Merck's monkeys, hoping to get some perspective on the differences between different types of AIDS inoculations.